AAAAAA
Results:
1-13
|
Results: 13
Authors:
KERN W
BRAESS J
BERTZ H
POTT C
SCHLEYER E
FINKE J
RUCHEL R
HIDDEMANN W
Citation: W. Kern et al., CHRONIC SYSTEMIC ASPERGILLOSIS IN A PATIENT WITH ACUTE MYELOID-LEUKEMIA, Annals of hematology, 76(3-4), 1998, pp. 175-177
Authors:
STRUTZ F
WIENEKE U
BRAESS J
KABOTH U
KNEBA M
RUMPF KW
GRUPP C
MULLER GA
Citation: F. Strutz et al., TREATMENT OF RELAPSING THROMBOTIC THROMBOCYTOPENIC PURPURA WITH CYCLOPHOSPHAMIDE PULSE THERAPY, Nephrology, dialysis, transplantation, 13(5), 1998, pp. 1320-1321
Authors:
KERN W
BRAESS J
GROTEMETKE A
KUSE H
FUCHS R
HOSSFELD DK
REICHLE A
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: W. Kern et al., COMBINATION OF ACLARUBICIN AND ETOPOSIDE FOR THE TREATMENT OF ADVANCED ACUTE MYELOID-LEUKEMIA - RESULTS OF A PROSPECTIVE MULTICENTER PHASE-II TRIAL, Leukemia, 12(10), 1998, pp. 1522-1526
Authors:
BRAESS J
FREUND M
HANAUSKE A
HEIL G
KAUFMANN C
KERN W
SCHUSSLER M
HIDDEMANN W
SCHLEYER E
Citation: J. Braess et al., ORAL CYTARABINE OCFOSFATE IN ACUTE MYELOID-LEUKEMIA AND NON-HODGKINS-LYMPHOMA - PHASE I II STUDIES AND PHARMACOKINETICS/, Leukemia, 12(10), 1998, pp. 1618-1626
Authors:
BRAESS J
REICH K
WILLERT S
STRUTZ F
NEUMANN C
HIDDEMANN W
WORMANN B
Citation: J. Braess et al., MUCOCUTANEOUS AUTOIMMUNE SYNDROME FOLLOWING FLUDARABINE THERAPY FOR LOW-GRADE NON-HODGKINS-LYMPHOMA OF B-CELL TYPE (B-NHL), Annals of hematology, 75(5-6), 1997, pp. 227-230
Authors:
SCHLEYER E
KUHN H
UNTERHALT M
KAUFMANN CC
KERN W
BRAESS J
STRAUBEL G
HIDDEMANN W
Citation: E. Schleyer et al., ORAL IDARUBICIN PHARMACOKINETICS - CORRELATION OF TROUGH LEVEL WITH IDARUBICIN AREA UNDER CURVE, Leukemia, 11, 1997, pp. 15-21
Authors:
KERN W
SCHLEYER E
BRAESS J
OHNESORGE J
UNTERHALT M
WORMANN B
BUCHNER T
HIDDEMANN W
Citation: W. Kern et al., FLUDARABINE, INTERMITTENT-SEQUENTIAL HIGH-DOSE CYTOSINE-ARABINOSIDE AND MITOXANTRONE (FIS-HAM) THERAPY IN ADVANCED ACUTE LEUKEMIAS, Blood, 90(10), 1997, pp. 3831-3831
Authors:
BRAESS J
FREUND M
HANAUSKE A
SCHUSSLER M
HIDDEMANN W
KERN W
UNTERHALT M
SCHLEYER E
Citation: J. Braess et al., PHASE-I STUDY OF ORAL CYTARABINE-OCPHOSPHATE (YNK01) IN AML AND NHL -PHARMACOKINETICS AND CLINICAL-RESULTS, Blood, 90(10), 1997, pp. 1473-1473
Authors:
BRAESS J
PFORTNER J
KAUFMANN CC
RAMSAUER B
UNTERHALT M
HIDDEMANN W
SCHLEYER E
Citation: J. Braess et al., DETECTION AND DETERMINATION OF THE MAJOR METABOLITES OF [H-3] CYTOSINE-ARABINOSIDE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical applications, 676(1), 1996, pp. 131-140
Authors:
BRAESS J
KERN W
UNTERHALT M
KAUFMANN CC
RAMSAUER B
SCHUSSLER M
KAESERFROHLICH A
HIDDEMANN W
SCHLEYER E
Citation: J. Braess et al., RESPONSE TO CYTARABINE OCFOSFATE (YNKO1) IN A PATIENT WITH CHRONIC LYMPHOCYTIC-LEUKEMIA REFRACTORY TO TREATMENT WITH CHLORAMBUCIL PREDNISONE, FLUDARABINE, AND PREDNIMUSTINE/MITOXANTRONE/, Annals of hematology, 73(4), 1996, pp. 201-204
Authors:
SCHLEYER E
KUHN S
RUHRS H
UNTERHALT M
KAUFMANN CC
KERN W
BRAESS J
STRAUBEL G
HIDDEMANN W
Citation: E. Schleyer et al., ORAL IDARUBICIN PHARMACOKINETICS - CORRELATION OF TROUGH LEVEL WITH IDARUBICIN AREA UNDER CURVE, Leukemia, 10(4), 1996, pp. 707-712
Authors:
RAMSAUER B
BRAESS J
UNTERHALT M
KAUFMANN CC
HIDDEMANN W
SCHLEYER E
Citation: B. Ramsauer et al., HIGHLY SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR 1-BETA-D-ARABINOFURANOSYLCYTOSINE-5'-STEARYL PHOSPHATE (CYTARABINE-OCFOSFATE), Journal of chromatography B. Biomedical applications, 665(1), 1995, pp. 183-192
Authors:
SCHLEYER E
BRAESS J
RAMSAUER B
UNTERHALT M
KAUFMANN C
WILDE S
SCHUSSLER M
HIDDEMANN W
Citation: E. Schleyer et al., PHARMACOKINETICS OF ARA-CMP-STEARATE (YNK01) - PHASE-I STUDY OF THE ORAL ARA-C DERIVATIVE, Leukemia, 9(6), 1995, pp. 1085-1090
Risultati:
1-13
|